Sprinter Health, which provides on-demand mobile laboratory testing services, raised $33 million in Series A funding. The company currently operates in the San Francisco Bay Area and Sacramento in California, and by the end of 2021 plans to expand its service area to Los Angeles and San Diego. In 2022, it plans to expand to Texas and Florida, and is considering other states.
The Sprinter Health service can be used for adults and for children who weigh at least 40 pounds. Appointments are booked online, and are often available for the same day or next day. Within each service area, appointments are available Monday through Friday, from 7:00 AM to 3:00 PM. The services are paid by credit card when the appointment is booked. The company does not participate in health insurance networks. People using the service pay $79 for a blood draw, and pay $99 for a rapid antigen test for coronavirus disease 2019 (COVID-19). The samples are delivered the consumer’s designated lab, which shares the test results with the consumer’s designated health care professional.
Physicians can partner with Sprinter Health to offer the service to their consumers. The nurses and phlebotomists who provide the mobile testing services are full-time Sprinter Health employees.
The funding round was led by Andreessen Horowitz. Other backers include General Catalyst, which led the company’s seed round, GV, Accel, and DoorDash chief executive officer Tony Xu. Julie Yoo, a general partner at Andreessen Horowitz, will be joining the Sprinter Health’s board of directors. Sprinter Health previously raised a $4.6 million seed round in March 2021, led by Hemant Taneja at General Catalyst, with angel investors including the Oculus founders, Kevin Lin (co-founder of Twitch), Jason Rubin, and John Lagerling.
This was reported by Sprinter Health on October 13, 2021.